Shallcross Steven a, CEO and CFO at Theriva Biologics, Inc. (TOVX), bought 25,000 shares at $0.87 ($22K) on 2023-01-25, disclosed to the SEC on 2023-01-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| TOVX | BUY | 2023-02-13 | $26K | — | Filing → |
| TOVX | BUY | 2023-02-03 | $24K | — | Filing → |
| TOVX | BUY | 2023-01-23 | $19K | — | Filing → |